Siemens Healthineers AG Stock

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 11:09:37 2024-06-17 EDT 5-day change 1st Jan Change
52.57 EUR -1.99% Intraday chart for Siemens Healthineers AG -3.80% +0.23%

Financials

Sales 2024 * 22.68B 24.3B 33.43B Sales 2025 * 24.25B 25.99B 35.75B Capitalization 59.85B 64.13B 88.23B
Net income 2024 * 2.02B 2.16B 2.98B Net income 2025 * 2.56B 2.74B 3.77B EV / Sales 2024 * 3.16 x
Net Debt 2024 * 11.87B 12.72B 17.5B Net Debt 2025 * 10.52B 11.28B 15.51B EV / Sales 2025 * 2.9 x
P/E ratio 2024 *
29.8 x
P/E ratio 2025 *
23.5 x
Employees 71,000
Yield 2024 *
1.91%
Yield 2025 *
2.31%
Free-Float 23.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.03%
1 week-3.80%
Current month-1.24%
1 month-0.30%
3 months-5.01%
6 months-0.64%
Current year+0.23%
More quotes
1 week
52.62
Extreme 52.62
55.52
1 month
52.56
Extreme 52.56
55.52
Current year
49.20
Extreme 49.2
58.14
1 year
44.39
Extreme 44.39
58.14
3 years
40.32
Extreme 40.32
67.66
5 years
28.50
Extreme 28.5
67.66
10 years
28.50
Extreme 28.5
67.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 17-12-31
Director of Finance/CFO 57 17-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 22-10-31
Director/Board Member 57 21-03-22
Director/Board Member 72 18-02-28
More insiders
Date Price Change Volume
24-06-17 52.68 -1.79% 171 001
24-06-14 53.64 -0.96% 604,362
24-06-13 54.16 -1.42% 551,929
24-06-12 54.94 0.00% 559,342
24-06-11 54.94 +0.26% 413,519

Delayed Quote Xetra, June 17, 2024 at 10:54 am

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
53.64 EUR
Average target price
60.47 EUR
Spread / Average Target
+12.73%
Consensus